Web Analytics

3 Latest Announced Rounds

  • $582,532,500
    Unknown

    4 Investors

    Technology, Information and Internet
    Dec 5th, 2025
  • $18,000,000
    Seed

    1 Investors

    Computer & Network Security
    Dec 5th, 2025
  • $28,000,000
    Unknown

    3 Investors

    Computer & Network Security
    Dec 5th, 2025
$3,601.59M Raised in 63 Funding Rounds in the past 7 Days - View All

Funding Round Profile

Indapta Therapeutics

start up
United States - Seattle & Houston
  • 18/12/2024
  • Unknown
  • $22,500,000

Indapta's allogeneic g-NK cells have highly potent ADCC activity, making them the ideal therapy to combine with IgG1 monoclonal antibodies, ADCs, or innate immune cell engager molecules.


Related People

Mark FrohlichFounder

Mark Frohlich United States - Greater Seattle Area

N/A